Evidence map›Paper›PMID 41996866›Full record

ReviewCurrent opinion in microbiology2026

Innate immune responses to Rickettsia: emerging themes and contrasts between species.

Nghi Ly, Alejandro A Guzman, Patrik Engström, Thomas P Burke

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nghi LyDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92617, USA.
Alejandro A GuzmanDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92617, USA.
Patrik EngströmPrimrose Bio, San Diego, CA 92121, USA.
Thomas P BurkeDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92617, USA. Electronic address: tpburke@uci.edu.

Funding

MARC PROGRAM AT THE UNIVERSITY OF CALIFORNIA, IRVINET34GM136498 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Roberto Tinoco · 2020 to 2026
$6.5M
Deciphering innate and adaptive immune responses to Rickettsia parkeriR01AI185119 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Thomas P Burke · 2025 to 2026
$1.5M
T32 for Training in Microbiology & Infectious DiseasesT32AI141346 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Celia Goulding, Melissa Bruckner Lodoen · 2019 to 2026
$1.0M
NIAID NIH HHS R01 AI185119NIAID NIH HHS T32 AI141346NIGMS NIH HHS T34 GM136498
6 · The paper itself

Abstract

Over 10 species of Rickettsia cause serious human disease across the globe, including deadly spotted fever and typhus. These arthropod-borne microbes and their close relatives are the only bacteria that obligately reside in the eukaryotic cytosol, making them distinctive tools to study innate immunity. Yet, the molecular details on how Rickettsia species interact with innate immunity have remained largely enigmatic. Recent advances are revealing that Rickettsia species are not only distinct from other bacterial pathogens that reside in the cytosol, but in some cases, they are highly distinct from one another in how they manipulate mammalian immune pathways. Here, we review an emerging paradigm that detection of Rickettsia species by inflammasomes appears largely conserved, whereby the pathogenic species largely evade inflammasomes, yet subpopulations can be detected after infrequent bacteriolysis. In contrast, different Rickettsia species have highly unique interactions with antibacterial autophagy (xenophagy), whereby some species evolved sophisticated mechanisms to avoid ubiquitylation, whereas others co-opt xenophagy to their benefit. Lastly, we review emerging literature regarding the role of immune cells in infection, which are increasingly appreciated as major targets in vivo. These insights set the stage for an exciting era of leveraging Rickettsia as powerful microbial tools to unravel how cytosolic pathogens subvert mammalian innate immune systems.

Indexed as

Immunity, InnateRickettsiaRickettsia InfectionsAnimalsAutophagyHost-Pathogen InteractionsHumansInflammasomesInnate Immunity RecognitionInflammasomes

Identifiers

PMID41996866
PMCPMC13151960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.